VIAL
Home/Compounds/Ca-AKG
MetabolicFDA ApprovedClinical Trials

Ca-AKG

About

About Ca-AKG

Calcium alpha-ketoglutarate (Ca-AKG) is a calcium salt of alpha-ketoglutarate, a key TCA cycle intermediate and epigenetic cofactor, shown in a clinical trial to reduce biological age by 8 years on epigenetic clocks after 7 months of supplementation. It supports collagen synthesis, serves as an ammonia scavenger, and acts as a cofactor for TET enzymes and histone demethylases that regulate DNA methylation patterns of aging.

Science

Mechanism of Action

Serves as an obligate cofactor for alpha-ketoglutarate-dependent dioxygenases including TET1/2/3 (DNA demethylation) and histone demethylases (KDMs), restoring youthful epigenetic patterns; also fuels the TCA cycle and reduces toxic ammonia accumulation in tissues.

Dosing

Typical Protocol

1,000–3,000 mg oral daily, split into 2 doses; the clinical trial showing epigenetic age reversal used 1,000 mg twice daily.

⚠ Protocol information is for educational purposes only. Dosing must be determined by a licensed physician based on individual health status and goals.

Regulatory

Legal Status in 2026

FDA Approved

This compound has completed clinical trials and received formal FDA approval for one or more indications. It can be legally prescribed by licensed physicians, filled at any licensed pharmacy, and may be covered by insurance. Off-label use by physicians is also legal. This is the highest level of regulatory clearance available in the US.

Evidence

Evidence Tier

Clinical Trials

Evidence from randomized controlled trials (RCTs) or large observational studies in humans. This is the gold standard — effects have been measured in controlled conditions and results are peer-reviewed and reproducible.

Find a Verified Provider

See which Vial-verified providers offer Ca-AKG — with trust scores, legal credentials, and pricing transparency.

Browse all verified providers →